Possis Medical
This article was originally published in The Gray Sheet
Executive Summary
Minneapolis, Minnesota device firm submits 510(k) to FDA for its Perma-Seal dialysis access graft. The company describes the graft as a "synthetic conduit for use as a point of vascular access in kidney dialysis patients"